Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests
Sunday, June 2, 2013 - 13:00
in Health & Medicine
Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life.